|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:European_Union
|
|
gptkbp:ATCCode
|
N06BX13
|
|
gptkbp:brand
|
gptkb:Catena
gptkb:Raxone
|
|
gptkbp:CASNumber
|
58186-27-9
|
|
gptkbp:chemicalFormula
|
C19H30O5
|
|
gptkbp:discoveredBy
|
gptkb:Takeda_Pharmaceutical_Company
|
|
gptkbp:discoveredIn
|
1980s
|
|
gptkbp:hasInChIKey
|
QGANZTPVLKGBSP-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCC(O)C
|
|
gptkbp:hasTherapeuticUse
|
treatment of Friedreich's ataxia
treatment of Leber's hereditary optic neuropathy
|
|
gptkbp:hasUNII
|
833P6QCX4S
|
|
gptkbp:isInClinicalTrialFor
|
gptkb:Duchenne_muscular_dystrophy
primary progressive multiple sclerosis
|
|
gptkbp:isNotApprovedIn
|
gptkb:Australia
gptkb:Canada
gptkb:Japan
gptkb:United_States
|
|
gptkbp:isSolubleIn
|
gptkb:DMSO
gptkb:methanol
ethanol
|
|
gptkbp:IUPACName
|
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
|
|
gptkbp:KEGGID
|
D04441
|
|
gptkbp:legalStatus
|
prescription only (in some countries)
|
|
gptkbp:mechanismOfAction
|
gptkb:antioxidant
electron carrier in mitochondria
|
|
gptkbp:meltingPoint
|
52-54°C
|
|
gptkbp:molecularWeight
|
338.44 g/mol
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1092
3673
3546
DB09046
|
|
gptkbp:relatedTo
|
gptkb:coenzyme_Q10
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
headache
gastrointestinal upset
nasopharyngitis
|
|
gptkbp:bfsParent
|
gptkb:Prevage
gptkb:Akatinol
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
idebenone
|